logo-loader
Volpara Health Technologies Ltd

Volpara Health Technologies delivers 200% growth with analysts tipping more to come

Given recurring revenue streams provide earnings predictability, Volpara is a stock that could generate interest.

Picture of monitors in laboratory
The broker noted that the company now has 57 SaaS customers, up from 14 at the start of the year

Volpara Health Technologies Ltd (ASX:VHT), has exceeded the commercial milestone of 200% growth in annual recurring revenue (ARR) set by the company for the 2018 financial year.

This news was well received by brokers and investors alike as the company's shares went close to matching their 12-month high of 80 cents.

WATCH: Volpara Health Technologies developing products and international sales networks

However, there appears to have been some profit-taking despite the company's proven success in identifying breast cancer at an early stage.

The pullback to 75 cents could represent a buying opportunity.

Given recurring revenue streams provide earnings predictability, Volpara is a stock that could generate interest.

Revenue growth of more than 100% over next two years

Volpara is a digital health company focused on early detection of breast cancer through improving quality of screening using artificial intelligence (AI).

Morgans analyst Scott Power noted that the company now has 57 SaaS customers, up from 14 at the start of the year.

This indicates a high level of customer acceptance for the product which augurs well for further strong growth in fiscal 2019.

He is forecasting revenues to more than double from $3.2 million in fiscal 2018 to $8.4 million in 2019 with similar proportionate growth taking revenues to $18.9 million in 2020.

Price target implies upside of nearly 10%

Power has an add recommendation on the stock with a price target of 81 cents, implying upside of 8% to its current price.

He is monitoring the rate of customer adoption and this would appear to be the main share price driver in the near term.

Quick facts: Volpara Health Technologies Ltd

Price: $1.52

Market: ASX
Market Cap: $330.96 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

'May only be a matter of time' before Uranium price recovery with...

Mining Capital's Alastair Ford discusses the planned slow down in production from Kazatomprom (LON:KAP). The miner's looking to cut output from its Kazakh mines by around 20% through to 2021. He says that extends the timeframe of its previous production curtailment by a further year, and...

1 day, 15 hours ago

2 min read